[Skip to Content]
[Skip to Content Landing]
Views 217
Citations 0
News From the Food and Drug Administration
April 18, 2017

Relief for Dust Mite Allergy

JAMA. 2017;317(15):1518. doi:10.1001/jama.2017.3630

Adults with dust mite allergy have a new option for symptom relief. Odactra, the first sublingual allergen extract for house dust mite–induced nasal inflammation with or without conjunctivitis has received FDA approval for use in patients aged 18 to 65 years.

Allergy symptoms to the microscopic bugs found in house dust that are related to ticks and spiders include cough, runny nose, nasal itching, nasal congestion, sneezing, and itchy and watery eyes. The symptoms “can negatively impact a person’s quality of life,” Peter Marks, MD, PhD, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement.

First Page Preview View Large
First page PDF preview
First page PDF preview
×